NeuroOne Medical Technologies Corporation Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-03-31 was 0.00 shares.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-09-30 was 0.00 shares.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-06-30 was 780.00 shares, a 93.12% decline year-over-year.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2020-09-30 was 0.00 shares.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 1.54K shares, a 93.97% decline from fiscal 2020.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 25.52K shares, a 87.12% decline from fiscal 2019.
- NeuroOne Medical Technologies Corporation share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was 198.04K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-03-31 | 0.00 shares 10-Q/A · filed 2026-06-12 | |
| 2021-09-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | 1.54K shares 10-K · filed 2022-12-22 |
| 2021-06-30 | 780.00 shares 10-Q · filed 2021-08-13 | |
| 2020-09-30 | 0.00 shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-31 | 25.52K shares 10-K/A · filed 2022-05-31 |
| 2020-06-30 | 11.34K shares 10-Q · filed 2021-08-13 | |
| 2019-09-30 | 198.04K shares 10-K · filed 2019-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |